A tocolytic is a medication used to temporarily slow or stop uterine contractions during preterm labor. The goal isn’t to prevent delivery altogether. Instead, tocolytics buy a critical window of time, typically 48 hours, so that other treatments can be given to protect the baby before birth. That short delay allows doctors to administer corticosteroids that help the baby’s lungs mature and, when necessary, to transfer the mother to a hospital with a specialized neonatal unit.
How Uterine Contractions Work
To understand what tocolytics do, it helps to know what drives a contraction in the first place. The muscular wall of the uterus contracts through a process powered by calcium. When a muscle cell in the uterus depolarizes (essentially fires an electrical signal), calcium channels on the cell surface open and calcium floods in. That calcium binds to a protein called calmodulin, which triggers a chain reaction that causes the muscle fibers to shorten and tighten. Each contraction is accompanied by a surge of calcium, and if you block that surge, the contraction stops.
This process is spontaneous. It doesn’t require a nerve signal or a hormonal trigger to start, though hormones like oxytocin can amplify it. Tocolytics interrupt contractions at different points in this calcium-driven cycle, depending on the type of drug.
Types of Tocolytics
Several classes of medication can suppress uterine contractions. Each works through a different mechanism, and the choice depends on how far along the pregnancy is, the mother’s health, and how the baby is doing.
Calcium Channel Blockers
These drugs block the channels that let calcium enter uterine muscle cells. Without that calcium influx, the muscle can’t contract effectively. Nifedipine is the most commonly used drug in this class. It’s taken by mouth, which makes it practical and easy to administer. Nifedipine was originally developed to treat high blood pressure and chest pain, but it has become one of the most widely used tocolytics worldwide because of its effectiveness and relatively mild side effect profile.
Beta-Adrenergic Receptor Agonists
These medications activate specific receptors on uterine muscle cells that promote relaxation. When these receptors are stimulated, the cells produce a signaling molecule that causes smooth muscle to relax. Terbutaline and ritodrine are the best-known drugs in this category. They work quickly, but they come with notable cardiovascular side effects for the mother, including rapid heart rate, drops in blood pressure, and in rare cases, fluid buildup in the lungs or heart rhythm problems. Because of these risks, their use has declined in favor of other options.
Prostaglandin Inhibitors
Prostaglandins are hormone-like substances that promote inflammation and stimulate uterine contractions. Nonsteroidal anti-inflammatory drugs (NSAIDs) block the enzymes that produce prostaglandins, which reduces contractile activity. Indomethacin is the primary NSAID used for this purpose. It’s effective, but it carries specific risks for the baby, particularly constriction of a key blood vessel called the ductus arteriosus, which the fetus relies on for circulation before birth. It can also reduce the amount of amniotic fluid. These risks are more serious at later gestational ages, and indomethacin is generally avoided after about 32 weeks of pregnancy. Research published in the New England Journal of Medicine found that these complications are most frequent in babies born at or before 30 weeks’ gestation who were exposed to the drug.
Oxytocin Receptor Antagonists
Oxytocin is the hormone most associated with labor contractions. It binds to receptors on uterine muscle cells and triggers the calcium cascade that leads to contraction. Atosiban is a synthetic compound designed to sit on those same receptors and block oxytocin from activating them. Because it was developed specifically for preterm labor rather than repurposed from another use, it tends to have fewer off-target side effects. Atosiban is widely used in Europe and other regions but is not approved in the United States. Two other oxytocin receptor antagonists, barusiban and retosiban, have been tested in humans but are not yet in clinical use.
Magnesium Sulfate
Magnesium sulfate has long been used in obstetrics, and its exact mechanism for calming uterine contractions isn’t fully understood. It appears to inhibit calcium from entering muscle cells and also dilates blood vessels supplying the uterus. Its role has shifted over time. While it was once used primarily as a tocolytic, it is now more commonly given for a different reason: protecting the baby’s brain. A pooled analysis of clinical trials found that magnesium sulfate given before early preterm birth reduces the risk of cerebral palsy in surviving infants by about 29%. The American College of Obstetricians and Gynecologists supports its use for this neuroprotective purpose.
Nitroglycerin
Nitroglycerin, better known for treating heart-related chest pain, can relax uterine muscle by boosting production of a molecule that prevents calcium levels from rising inside cells. It also interferes with the muscle’s ability to sustain contractions. It’s used less commonly than the other options and is sometimes reserved for situations where rapid, short-term relaxation of the uterus is needed.
Why 48 Hours Matters
Tocolytics do not dramatically extend pregnancy in most cases. The consistent finding across clinical trials is that they reliably delay delivery for about 48 hours. That might sound modest, but those two days serve a specific and well-supported purpose. A full course of corticosteroids, which accelerate the baby’s lung development, takes 48 hours to reach full effect. Babies born prematurely without this steroid boost face significantly higher rates of breathing problems, brain bleeding, and death. The 48-hour window also provides time to transfer a mother from a community hospital to a facility with a neonatal intensive care unit, which improves outcomes for very premature infants.
There is no strong evidence that tocolytics, on their own, improve long-term outcomes for premature babies. Their value lies almost entirely in creating that window for other interventions.
When Tocolytics Are Not Used
Tocolytics are not appropriate in every case of preterm labor. There are situations where continuing the pregnancy would pose more danger to the mother or baby than early delivery would. Infections inside the uterus, severe preeclampsia, heavy bleeding from placental problems, and signs that the baby is in distress are all reasons to let labor proceed rather than suppress it. If the baby has already died or has a condition incompatible with survival, tocolysis serves no purpose. The decision always involves weighing the risks of prematurity against the risks of prolonging a complicated pregnancy.
Side Effects and Tradeoffs
Because tocolytics were mostly developed for other medical conditions and later repurposed for preterm labor, their side effects often reflect their original uses. Nifedipine can cause flushing, headaches, and drops in blood pressure, consistent with its role as a blood pressure medication. Beta-agonists like terbutaline can cause a racing heart, tremors, and shortness of breath. Reports linked to terbutaline use in preterm labor have included serious cardiovascular events: heart rhythm abnormalities, heart attacks, fluid in the lungs, and in rare cases, maternal death. These risks are one reason beta-agonists have fallen out of favor as first-line tocolytics in many countries.
Indomethacin’s risks are primarily to the baby rather than the mother. Beyond the ductus arteriosus constriction, it can affect the baby’s kidney function, platelet activity, and blood flow to the brain and gut. These effects are more dangerous at earlier gestational ages, which creates a narrow window where the drug is both useful and reasonably safe, roughly between 24 and 32 weeks.
Atosiban stands out for having fewer maternal side effects than most alternatives, largely because it was designed to target uterine oxytocin receptors specifically. Its main limitation is availability, since it remains unavailable in some countries including the United States.